Filing Details
- Accession Number:
- 0001209191-19-037201
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-14 17:21:25
- Reporting Period:
- 2019-04-12
- Accepted Time:
- 2019-06-14 17:21:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-04-12 | 99 | $6.32 | 5,760,899 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-17 | 81 | $6.21 | 5,760,980 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-24 | 32 | $6.04 | 5,761,012 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-25 | 24 | $6.17 | 5,761,036 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-26 | 14 | $6.32 | 5,761,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-30 | 27 | $6.37 | 5,761,077 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-02 | 73 | $5.61 | 5,761,150 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-06 | 42 | $6.29 | 5,761,192 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-07 | 23 | $6.07 | 5,761,215 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-08 | 58 | $6.35 | 5,761,273 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-10 | 57 | $6.01 | 5,761,330 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-14 | 36 | $5.62 | 5,761,366 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-17 | 106 | $6.25 | 5,761,472 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-20 | 60 | $6.89 | 5,761,532 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-21 | 60 | $6.71 | 5,761,592 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-22 | 60 | $6.58 | 5,761,652 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-23 | 60 | $6.53 | 5,761,712 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-24 | 60 | $6.67 | 5,761,772 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-28 | 60 | $6.65 | 5,761,832 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-29 | 60 | $6.53 | 5,761,892 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-30 | 60 | $6.58 | 5,761,952 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-31 | 60 | $6.57 | 5,762,012 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-03 | 60 | $6.49 | 5,762,072 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-04 | 60 | $6.60 | 5,762,132 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-05 | 50 | $6.67 | 5,762,182 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-06 | 60 | $6.38 | 5,762,242 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-07 | 60 | $6.07 | 5,762,302 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-10 | 60 | $6.09 | 5,762,362 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-11 | 60 | $6.32 | 5,762,422 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-12 | 60 | $6.29 | 5,762,482 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.